Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-β

Blood

Volumn 89, Issue 3, 1997, Pages 941-947

  Douglas, Raymond S ^a   Capocasale, Renold J ^a   Lamb, Roberta J ^a   Nowell, Peter C ^a   Moore, Jonni S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; DIAGNOSIS; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL;

EID: 0030986972     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.3.941     Document Type: Article

References (36)

1. Li FP: Epidemiology of chronic leukemias, in Weirnik PH, Canellos GP, Kyle RA, Schiffer CA (eds): Neoplastic Diseases of the Blood (ed 2). New York, NY, Churchill Livingstone, 1991, p 7
2. Melo JV, Catovsky D, Galton DAG: The relationship between chronic lymphocytic leukemia and prolymphocytic leukemia. I. Clinical and laboratory fetaures of 300 patients and characterization of an intermediate group. Br J Haematol 63:377, 1986
3. Aisenberg AC, Block KS: Immunoglobulins on the surface of neoplastic lymphocytes. N Engl J Med 287:272, 1972
4. Mauer AM: Clinical features of human leukemia, in Mauer AM (ed): The Biology of Human Leukemia. Baltimore, MD, Johns Hopkins University Press, 1990, p 1
5. Moore JS, Friedman DF, Silberstein LE, Besa EC, Nowell PC: Clinical heterogeneity reflects biologic diversity in chronic lymphocytic leukemia. Crit Rev Oncol/Hematol 20:141, 1995
6. Miyashita T, Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151, 1993
7. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC: Bcl-2 gene hypermethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820, 1993
8. Rabbitts TH: Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 67:641, 1991
9. Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet JL: B cell chronic lymphocytic leukemia: Present status and future directions. Blood 78:1901, 1991
10. Schwartz RJ, Cost N: Autoimmune hemolytic anemia: Clinical correlations and biologic implications. Semin Hematol 3:226, 1966
11. Hoffbrand AV, Panayiotidis P, Reittie J, Ganeshaguru K: Autocrine and paracrine growth loops in chronic lymphocytic leukemia. Semin Hematol 30:306, 1993
12. Chaouchi N, Arvanitakis L, Auffredou MT, Blanchard DA, Vazquez A, Sharma S: Characterization of transforming growth factor-beta1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene 11:1615, 1995
13. Kremer JP, Reisbach G, Nerl C, Dormer P: B-cell chronic lymphocytic leukaemia cells express and release transforming growth factor-beta. Br J Heamatol 80:480, 1992
14. Lotz M, Raanheim E, Kipps T: Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J Exp Med 179:999, 1994
15. Moore JS, Capocasale RJ, Fox FE, Lamb RJ, Besa AC, Penziner AS, Nowell PC: Response of CLL B cells to transforming growth factor-beta reflects biological heterogeneity. Blood 82:573a, 1992 (abstr, suppl 1)
16. Capocasale RJ, Lamb RJ, Vonderheid EC, Fox FE, Rook AH, Nowell PC, Moore JS: Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sezary patients. Proc Natl Acad Sci USA 92:5501, 1995
17. Kadin ME, Cavaille-Coll MW, Gertz R, Massague J, Cheifetz S, George D: Loss of receptors for transforming growth factor beta in human T-cell malignancies. Proc Natl Acad Sci USA 91:6002, 1994
18. Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, Sarfati M: Interleukin-4 protects chronic lymphocytic leukemia B cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 176:1319, 1992
19. Karray S, DeFrance T, Merle-Beral H, Banchereau J, Debre P, Galanaud P: Interleukin 4 counteracts the interleukin 2 induced proliferation of monoclonal B cells. J Exp Med 168:85, 1988
20. Carlsson M, Sundstrom C, Bengtsson M, Totterman TH, Rosen A, Nilsson K: Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B cell type chronic lymphocytic leukemia cells depending on the costimulatory activation and progression signals. Eur J Immunol 19:913, 1989
21. DeFrance, T, Banchereau J: Role of cytokines in ontogeny, activation and proliferation of B lymphocytes, in Callard RE (ed): Cytokines and B Lymphocytes. San Diego, CA, Academic, 1990, p 65
22. Panayiotidis P, Ganeshaguru K, Jabbar SAB, Hoffbrand AV: IL-4 inhibits apoptotic cell death and loss of the Bcl-2 protein in BCLL cells in vitro. Br J Haematol 85:439, 1993
23. Gorczyca W, Bruno S, Darzynkiewicz RJ, Gong J, Darzynkiewicz Z: DNA strand breaks occurring during apoptosis: Their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol 1:639, 1992
24. Gorczyca W, Gong J, Darzynkiewicz Z: Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53:1945, 1993
25. Darzynkiewicz Z, Li X, Gong J: Assays of cell viability: Discrimination of cells dying by apoptosis. Meth Cell Biol 41:15, 1994
26. Moore JS, Prystowsky MB, Hoover RG, Besa EC, Nowell PC: Defective T-cell mediated, isotype-specific immunoglobulin regulation in B cell chronic lymphocyticleukemia. Blood 71:1012, 1988
27. Inagaki M, Moustakas A, Lin H, Lodish H, Carr B: Growth inhibition by transforming growth factor beta (TGF-beta) type 1 is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA. Proc Natl Acad Sci USA 90:1, 1993
28. Zola H, Flego L, Weedon H: Expression of IL-4 receptor on human T and B lymphocytes. Cell Immunol 150:149, 1993
29. Lagneaux L, Delforge A, Dorval C, Bron D, Stryckmans P: Excessive production of transforming growth factor beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production. Blood 82:2379, 1993
30. 2-type responses through direct and IL-10 mediated pathways in tumor-bearing mice. J Immunol 156:73, 1996
31. Maeda H, Kuwahara H, Ichimura Y, Ohtsuki M, Kurakata S, Shiraishi A: TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J Immunol 155:4926, 1995
32. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowski E, Kinzler KW, Vogelstein B, Brattain M, Willson JK: Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336, 1995
33. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1, 1994
34. Caligaris-Cappio F, Gobbi M, Bofill M, Janossy G: Infrequent normal B lymphocytes express features of B chronic lymphocytic leukemia. J Exp Med 155:623, 1982
35. Mackenzie LE, Mageed RA, Youinou Y, Yuksel B, Jeffries R, Lydyard M: Repetoire of CD5+ and CD5-cord blood B cells: Specificity and expression of VH I and VH III associated idiotypes. Clin Exp Immunol 88:107, 1992
36. Phillips JA, Mehta K, Fernandez C, Raveche ES: The NZB mouse as a model for chronic lymphocytic leukemia. Cancer Res 52:2, 1992